APA 6th Edition

Sajko, T. i Hećimović, H. (2013). Why is Epilepsy Surgery Better Option in Pharmacoresistant Patients. Acta clinica Croatica, 52. (Supplement 1), 21-21. Preuzeto s https://hrcak.srce.hr/107048

---

MLA 8th Edition

Sajko, Tomislav i Hrvoje Hećimović. "Why is Epilepsy Surgery Better Option in Pharmacoresistant Patients." Acta clinica Croatica, vol. 52., br. Supplement 1, 2013, str. 21-21. https://hrcak.srce.hr/107048. Citirano 22.12.2024.

---

Chicago 17th Edition

Sajko, Tomislav i Hrvoje Hećimović. "Why is Epilepsy Surgery Better Option in Pharmacoresistant Patients." Acta clinica Croatica 52., br. Supplement 1 (2013): 21-21. https://hrcak.srce.hr/107048

---

Harvard

Sajko, T., i Hećimović, H. (2013). 'Why is Epilepsy Surgery Better Option in Pharmacoresistant Patients', Acta clinica Croatica, 52.(Supplement 1), str. 21-21. Preuzeto s: https://hrcak.srce.hr/107048 (Datum pristupa: 22.12.2024.)

---

Vancouver

Sajko T, Hećimović H. Why is Epilepsy Surgery Better Option in Pharmacoresistant Patients. Acta clinica Croatica [Internet]. 2013 [pristupljeno 22.12.2024.];52.(Supplement 1):21-21. Dostupno na: https://hrcak.srce.hr/107048

---

IEEE

T. Sajko i H. Hećimović, "Why is Epilepsy Surgery Better Option in Pharmacoresistant Patients", Acta clinica Croatica, vol.52., br. Supplement 1, str. 21-21, 2013. [Online]. Dostupno na: https://hrcak.srce.hr/107048. [Citirano: 22.12.2024.]